Early-stage venture capital firm has closed a $600 million new fund, which it completely raised during the COVID-19 pandemic.
Subscribe to the 蹤獲弝け Daily
The new fund, CRV XVIII, is the same size as its previous fund although it was oversubscribed, according to a t from CRV. The firm decided to cap the fund at $600 million because it believed that was the right size for CRV���s investing team in the current climate.
���We believe it is essential to continue demonstrating to our entrepreneurs that we are disciplined investors���the same way we rely on them to be great stewards of capital,��� the post read. ���The venture world is swimming in excess capital. We never want to be the firm that thinks of ���putting money to work.��� We are helping entrepreneurs build their companies.���
While the world has been turned upside down by the COVID-19 pandemic and most in-person interactions have been on pause for several months, that didn���t have a negative effect on CRV���s fundraising abilities with its limited partners. According to CRV, the fund was raised over 19 days of virtual meetings during the pandemic.
The company focuses mostly on early-stage software investing, but it also has a consumer practice that has backed companies like and . The firm also has a bioengineering investing sector.
The has most recently invested in companies including , , Abacus Insights, and ,according to 蹤獲弝け. Some of its most notable exits are and IPOs, and acquisitions of and .
Illustration: Li-Anne Dias
Stay up to date with recent funding rounds, acquisitions, and more with the 蹤獲弝け Daily.


67.1K Followers